Given that p‐Bad inhibits apoptotic cell death induced by the intrinsic mitochondrial pathway 41, we sought to investigate whether PTPRK could be implicated in CD133‐associated anti‐cancer drug resistance of colon cancer cells. Here, PROM1 is linked to colonic neoplasm.